Matching slides 110,355
Current window 58,141-58,170
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all

Component

58,141-58,170 of 110,355

filter-aware
35
The slide uses a combination of a stacked bar chart for cost coverage over time and a 100% stacked bar chart for program value composition.Ginkgo | Investor Conference Presentation Deck | 38 slides · Ginkgo Bioworks
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
36
Includes footnotes regarding GAAP adjustments, CapEx, and NPV estimation methodology.Ginkgo | Investor Conference Presentation Deck | 38 slides · Ginkgo Bioworks
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
16
The slide uses a contrast-pair framework to highlight the superiority of their specific technical approach over the standard alternative.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank Beat · Solution & Approach1 hit
18
The chart shows a significant jump in beta-globin correction percentage with the optimized Graphite Bio approach.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank Beat · Solution & Approach1 hit
21
The slide uses a hub-and-spoke diagram to visualize the versatility of the platform.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank 1 hit
22
The slide uses a three-column structure to explain the biological basis, clinical proof-of-concept, and the company's specific therapeutic approach.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank 1 hit
24
Uses a before-after-bridge framing structure.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
25
The slide uses a scientific citation to validate the prevalence of the sickle trait.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
29
The slide uses a three-part process flow (Correct, Measure ex vivo, Measure in vivo) with corresponding data charts for each stage.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank Beat · Evidence1 hit
30
The slide uses a two-part process flow (correction then measurement) to validate the therapeutic approach.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank Beat · Satisfaction1 hit
31
The slide uses a before-and-after visual comparison to validate the efficacy of the gene correction technology.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank Beat · Satisfaction1 hit
35
Uses a funnel-like decomposition of the patient population.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank 1 hit
36
Uses a visual funnel/segmentation approach to show how the total patient population is filtered down to the target segment for the new therapy.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank 1 hit
37
SMC likely stands for Safety Monitoring Committee.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank 1 hit
39
The slide uses a three-column layout to explain the problem, the mechanism of action, and the future potential/conditioning strategy.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank 1 hit
40
The slide uses a bar chart to establish the clinical threshold for success in different disease areas, framing the company's antibody conditioning strategy.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank 1 hit
41
The slide uses a comparative framework to show how different genetic loci can be targeted for different therapeutic outcomes.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank 1 hit
42
The slide uses a process flow to explain the mechanism of action for a gene therapy platform.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank 1 hit
43
The chart illustrates the addressable market size for different genetic conditions targeted by the company's platform.Graphite Bio | IPO Presentation Deck | 50 slides · Graphite Bio
Pitch deck Investment bank 1 hit
03
Uses a pyramid to represent wealth tiers and donut charts for geographic distribution.HSBC | Investor Day Presentation Deck | 39 slides · HSBC
Conference presentation Investor relations Beat · Problem1 hit
04
The slide uses a pyramid-like structure for the strategy pillars under a unified mission statement.HSBC | Investor Day Presentation Deck | 39 slides · HSBC
Conference presentation Investor relations Beat · Problem1 hit
08
The slide uses a two-column layout to contrast growth goals with the investment required to achieve them.HSBC | Investor Day Presentation Deck | 39 slides · HSBC
Conference presentation Investor relations Beat · SolutionLoop · Why Now1 hit
23
The slide uses a before-after/comparison structure to highlight the shift from traditional commission-based sales to a salaried, needs-led model.HSBC | Investor Day Presentation Deck | 39 slides · HSBC
Conference presentation Investor relations Beat · Market Size1 hit
27
The slide uses a split-layout: left side for business metrics and historical AUM growth, right side for strategic pillars.HSBC | Investor Day Presentation Deck | 39 slides · HSBC
Conference presentation Investor relations Beat · Product1 hit
33
The slide uses stacked bar charts to show revenue and balance composition over two years.HSBC | Investor Day Presentation Deck | 39 slides · HSBC
Conference presentation Investor relations 1 hit
34
The slide uses stacked bar charts to show wealth distribution by net worth segment ($1-5m, $5-20m, $20m+) and CAGR growth rates.HSBC | Investor Day Presentation Deck | 39 slides · HSBC
Conference presentation Investor relations 1 hit
05
The chart uses a waterfall visualization to aggregate regional market sizes into a global total.Hydrafacial | Investor Presentation Deck | 25 slides · BeautyHealth
Pitch deck Investor relations Beat · Problem1 hit
08
Includes CAGR annotations and specific growth projections for U.S. spa services, facilities, and specialists.Hydrafacial | Investor Presentation Deck | 25 slides · BeautyHealth
Pitch deck Investor relations 1 hit
10
The slide uses a grid layout to categorize market trends. The top chart illustrates the spectrum of skin treatments from non-invasive to invasive.Hydrafacial | Investor Presentation Deck | 25 slides · BeautyHealth
Pitch deck Investor relations Loop · Why Now1 hit
13
The chart highlights HydraFacial with a blue bar and a dotted box for emphasis.Hydrafacial | Investor Presentation Deck | 25 slides · BeautyHealth
Pitch deck Investor relations 1 hit